Selected research
Market Analysis & Forecast
Global Pharmaceutical Outsourcing Analytical Testing Market Analysis and Forecast 2026-2032
Market perspective
The global Pharmaceutical Outsourcing Analytical Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Pharmaceutical Outsourcing Analytical Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Pharmaceutical Outsourcing Analytical Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Pharmaceutical Outsourcing Analytical Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Pharmaceutical Outsourcing Analytical Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Pharmaceutical Outsourcing Analytical Testing include Merck, Recro Gainesville, Recipharm, Quotient Sciences, Metrics Contract Services, Frontida Biopharm, Frontage, ENCO Pharmaceutical Development and Catalent, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Pharmaceutical Outsourcing Analytical Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Pharmaceutical Outsourcing Analytical Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Pharmaceutical Outsourcing Analytical Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pharmaceutical Outsourcing Analytical Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pharmaceutical Outsourcing Analytical Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pharmaceutical Outsourcing Analytical Testing revenue, projected growth trends, production technology, application and end-user industry.
Pharmaceutical Outsourcing Analytical Testing Segment by Company
Merck
Recro Gainesville
Recipharm
Quotient Sciences
Metrics Contract Services
Frontida Biopharm
Frontage
ENCO Pharmaceutical Development
Catalent
Aztech Sciences
Ascendia Pharmaceuticals
ARL Bio Pharma
Alcami
Pharmaceutical Outsourcing Analytical Testing Segment by Type
Stability Testing
Bioanalytical Testing
Method Development & Validation
Others
Pharmaceutical Outsourcing Analytical Testing Segment by Application
Small & Medium Enterprise
Large Enterprise
Pharmaceutical Outsourcing Analytical Testing Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Outsourcing Analytical Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Outsourcing Analytical Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Outsourcing Analytical Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Pharmaceutical Outsourcing Analytical Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Pharmaceutical Outsourcing Analytical Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Outsourcing Analytical Testing revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Stability Testing
- Bioanalytical Testing
- Method Development & Validation
- Others
Applications
- Small & Medium Enterprise
- Large Enterprise
Companies covered
- Merck
- Recro Gainesville
- Recipharm
- Quotient Sciences
- Metrics Contract Services
- Frontida Biopharm
- Frontage
- ENCO Pharmaceutical Development
- Catalent
- Aztech Sciences
- Ascendia Pharmaceuticals
- ARL Bio Pharma
- Alcami
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Pharmaceutical Outsourcing Analytical Testing Market by Type
- 1.2.1 Global Pharmaceutical Outsourcing Analytical Testing Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Stability Testing
- 1.2.3 Bioanalytical Testing
- 1.2.4 Method Development & Validation
- 1.2.5 Others
- 1.3 Pharmaceutical Outsourcing Analytical Testing Market by Application
- 1.3.1 Global Pharmaceutical Outsourcing Analytical Testing Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Small & Medium Enterprise
- 1.3.3 Large Enterprise
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Pharmaceutical Outsourcing Analytical Testing Market Dynamics
- 2.1 Pharmaceutical Outsourcing Analytical Testing Industry Trends
- 2.2 Pharmaceutical Outsourcing Analytical Testing Industry Drivers
- 2.3 Pharmaceutical Outsourcing Analytical Testing Industry Opportunities and Challenges
- 2.4 Pharmaceutical Outsourcing Analytical Testing Industry Restraints
3 Global Growth Perspective
- 3.1 Global Pharmaceutical Outsourcing Analytical Testing Market Perspective (2021-2032)
- 3.2 Global Pharmaceutical Outsourcing Analytical Testing Growth Trends by Region
- 3.2.1 Global Pharmaceutical Outsourcing Analytical Testing Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Pharmaceutical Outsourcing Analytical Testing Market Size by Region (2021-2026)
- 3.2.3 Global Pharmaceutical Outsourcing Analytical Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Pharmaceutical Outsourcing Analytical Testing Revenue by Players
- 4.1.1 Global Pharmaceutical Outsourcing Analytical Testing Revenue by Players (2021-2026)
- 4.1.2 Global Pharmaceutical Outsourcing Analytical Testing Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Pharmaceutical Outsourcing Analytical Testing Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Pharmaceutical Outsourcing Analytical Testing Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Pharmaceutical Outsourcing Analytical Testing Key Players Headquarters & Area Served
- 4.4 Global Pharmaceutical Outsourcing Analytical Testing Players, Product Type & Application
- 4.5 Global Pharmaceutical Outsourcing Analytical Testing Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Pharmaceutical Outsourcing Analytical Testing Market CR5 and HHI
- 4.6.3 2025 Pharmaceutical Outsourcing Analytical Testing Tier 1, Tier 2, and Tier 3
5 Pharmaceutical Outsourcing Analytical Testing Market Size by Type
- 5.1 Global Pharmaceutical Outsourcing Analytical Testing Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Pharmaceutical Outsourcing Analytical Testing Revenue by Type (2021-2032)
- 5.3 Global Pharmaceutical Outsourcing Analytical Testing Revenue Market Share by Type (2021-2032)
6 Pharmaceutical Outsourcing Analytical Testing Market Size by Application
- 6.1 Global Pharmaceutical Outsourcing Analytical Testing Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Pharmaceutical Outsourcing Analytical Testing Revenue by Application (2021-2032)
- 6.3 Global Pharmaceutical Outsourcing Analytical Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Merck
- 7.1.1 Merck Company Information
- 7.1.2 Merck Business Overview
- 7.1.3 Merck Pharmaceutical Outsourcing Analytical Testing Revenue and Gross Margin (2021-2026)
- 7.1.4 Merck Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 7.1.5 Merck Recent Developments
- 7.2 Recro Gainesville
- 7.2.1 Recro Gainesville Company Information
- 7.2.2 Recro Gainesville Business Overview
- 7.2.3 Recro Gainesville Pharmaceutical Outsourcing Analytical Testing Revenue and Gross Margin (2021-2026)
- 7.2.4 Recro Gainesville Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 7.2.5 Recro Gainesville Recent Developments
- 7.3 Recipharm
- 7.3.1 Recipharm Company Information
- 7.3.2 Recipharm Business Overview
- 7.3.3 Recipharm Pharmaceutical Outsourcing Analytical Testing Revenue and Gross Margin (2021-2026)
- 7.3.4 Recipharm Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 7.3.5 Recipharm Recent Developments
- 7.4 Quotient Sciences
- 7.4.1 Quotient Sciences Company Information
- 7.4.2 Quotient Sciences Business Overview
- 7.4.3 Quotient Sciences Pharmaceutical Outsourcing Analytical Testing Revenue and Gross Margin (2021-2026)
- 7.4.4 Quotient Sciences Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 7.4.5 Quotient Sciences Recent Developments
- 7.5 Metrics Contract Services
- 7.5.1 Metrics Contract Services Company Information
- 7.5.2 Metrics Contract Services Business Overview
- 7.5.3 Metrics Contract Services Pharmaceutical Outsourcing Analytical Testing Revenue and Gross Margin (2021-2026)
- 7.5.4 Metrics Contract Services Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 7.5.5 Metrics Contract Services Recent Developments
- 7.6 Frontida Biopharm
- 7.6.1 Frontida Biopharm Company Information
- 7.6.2 Frontida Biopharm Business Overview
- 7.6.3 Frontida Biopharm Pharmaceutical Outsourcing Analytical Testing Revenue and Gross Margin (2021-2026)
- 7.6.4 Frontida Biopharm Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 7.6.5 Frontida Biopharm Recent Developments
- 7.7 Frontage
- 7.7.1 Frontage Company Information
- 7.7.2 Frontage Business Overview
- 7.7.3 Frontage Pharmaceutical Outsourcing Analytical Testing Revenue and Gross Margin (2021-2026)
- 7.7.4 Frontage Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 7.7.5 Frontage Recent Developments
- 7.8 ENCO Pharmaceutical Development
- 7.8.1 ENCO Pharmaceutical Development Company Information
- 7.8.2 ENCO Pharmaceutical Development Business Overview
- 7.8.3 ENCO Pharmaceutical Development Pharmaceutical Outsourcing Analytical Testing Revenue and Gross Margin (2021-2026)
- 7.8.4 ENCO Pharmaceutical Development Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 7.8.5 ENCO Pharmaceutical Development Recent Developments
- 7.9 Catalent
- 7.9.1 Catalent Company Information
- 7.9.2 Catalent Business Overview
- 7.9.3 Catalent Pharmaceutical Outsourcing Analytical Testing Revenue and Gross Margin (2021-2026)
- 7.9.4 Catalent Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 7.9.5 Catalent Recent Developments
- 7.10 Aztech Sciences
- 7.10.1 Aztech Sciences Company Information
- 7.10.2 Aztech Sciences Business Overview
- 7.10.3 Aztech Sciences Pharmaceutical Outsourcing Analytical Testing Revenue and Gross Margin (2021-2026)
- 7.10.4 Aztech Sciences Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 7.10.5 Aztech Sciences Recent Developments
- 7.11 Ascendia Pharmaceuticals
- 7.11.1 Ascendia Pharmaceuticals Company Information
- 7.11.2 Ascendia Pharmaceuticals Business Overview
- 7.11.3 Ascendia Pharmaceuticals Pharmaceutical Outsourcing Analytical Testing Revenue and Gross Margin (2021-2026)
- 7.11.4 Ascendia Pharmaceuticals Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 7.11.5 Ascendia Pharmaceuticals Recent Developments
- 7.12 ARL Bio Pharma
- 7.12.1 ARL Bio Pharma Company Information
- 7.12.2 ARL Bio Pharma Business Overview
- 7.12.3 ARL Bio Pharma Pharmaceutical Outsourcing Analytical Testing Revenue and Gross Margin (2021-2026)
- 7.12.4 ARL Bio Pharma Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 7.12.5 ARL Bio Pharma Recent Developments
- 7.13 Alcami
- 7.13.1 Alcami Company Information
- 7.13.2 Alcami Business Overview
- 7.13.3 Alcami Pharmaceutical Outsourcing Analytical Testing Revenue and Gross Margin (2021-2026)
- 7.13.4 Alcami Pharmaceutical Outsourcing Analytical Testing Product Portfolio
- 7.13.5 Alcami Recent Developments
8 North America
- 8.1 North America Pharmaceutical Outsourcing Analytical Testing Revenue (2021-2032)
- 8.2 North America Pharmaceutical Outsourcing Analytical Testing Revenue by Type (2021-2032)
- 8.2.1 North America Pharmaceutical Outsourcing Analytical Testing Revenue by Type (2021-2026)
- 8.2.2 North America Pharmaceutical Outsourcing Analytical Testing Revenue by Type (2027-2032)
- 8.3 North America Pharmaceutical Outsourcing Analytical Testing Revenue Share by Type (2021-2032)
- 8.4 North America Pharmaceutical Outsourcing Analytical Testing Revenue by Application (2021-2032)
- 8.4.1 North America Pharmaceutical Outsourcing Analytical Testing Revenue by Application (2021-2026)
- 8.4.2 North America Pharmaceutical Outsourcing Analytical Testing Revenue by Application (2027-2032)
- 8.5 North America Pharmaceutical Outsourcing Analytical Testing Revenue Share by Application (2021-2032)
- 8.6 North America Pharmaceutical Outsourcing Analytical Testing Revenue by Country
- 8.6.1 North America Pharmaceutical Outsourcing Analytical Testing Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Pharmaceutical Outsourcing Analytical Testing Revenue by Country (2021-2026)
- 8.6.3 North America Pharmaceutical Outsourcing Analytical Testing Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
9 Europe
- 9.1 Europe Pharmaceutical Outsourcing Analytical Testing Revenue (2021-2032)
- 9.2 Europe Pharmaceutical Outsourcing Analytical Testing Revenue by Type (2021-2032)
- 9.2.1 Europe Pharmaceutical Outsourcing Analytical Testing Revenue by Type (2021-2026)
- 9.2.2 Europe Pharmaceutical Outsourcing Analytical Testing Revenue by Type (2027-2032)
- 9.3 Europe Pharmaceutical Outsourcing Analytical Testing Revenue Share by Type (2021-2032)
- 9.4 Europe Pharmaceutical Outsourcing Analytical Testing Revenue by Application (2021-2032)
- 9.4.1 Europe Pharmaceutical Outsourcing Analytical Testing Revenue by Application (2021-2026)
- 9.4.2 Europe Pharmaceutical Outsourcing Analytical Testing Revenue by Application (2027-2032)
- 9.5 Europe Pharmaceutical Outsourcing Analytical Testing Revenue Share by Application (2021-2032)
- 9.6 Europe Pharmaceutical Outsourcing Analytical Testing Revenue by Country
- 9.6.1 Europe Pharmaceutical Outsourcing Analytical Testing Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Pharmaceutical Outsourcing Analytical Testing Revenue by Country (2021-2026)
- 9.6.3 Europe Pharmaceutical Outsourcing Analytical Testing Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Netherlands
10 China
- 10.1 China Pharmaceutical Outsourcing Analytical Testing Revenue (2021-2032)
- 10.2 China Pharmaceutical Outsourcing Analytical Testing Revenue by Type (2021-2032)
- 10.2.1 China Pharmaceutical Outsourcing Analytical Testing Revenue by Type (2021-2026)
- 10.2.2 China Pharmaceutical Outsourcing Analytical Testing Revenue by Type (2027-2032)
- 10.3 China Pharmaceutical Outsourcing Analytical Testing Revenue Share by Type (2021-2032)
- 10.4 China Pharmaceutical Outsourcing Analytical Testing Revenue by Application (2021-2032)
- 10.4.1 China Pharmaceutical Outsourcing Analytical Testing Revenue by Application (2021-2026)
- 10.4.2 China Pharmaceutical Outsourcing Analytical Testing Revenue by Application (2027-2032)
- 10.5 China Pharmaceutical Outsourcing Analytical Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Pharmaceutical Outsourcing Analytical Testing Revenue (2021-2032)
- 11.2 Asia Pharmaceutical Outsourcing Analytical Testing Revenue by Type (2021-2032)
- 11.2.1 Asia Pharmaceutical Outsourcing Analytical Testing Revenue by Type (2021-2026)
- 11.2.2 Asia Pharmaceutical Outsourcing Analytical Testing Revenue by Type (2027-2032)
- 11.3 Asia Pharmaceutical Outsourcing Analytical Testing Revenue Share by Type (2021-2032)
- 11.4 Asia Pharmaceutical Outsourcing Analytical Testing Revenue by Application (2021-2032)
- 11.4.1 Asia Pharmaceutical Outsourcing Analytical Testing Revenue by Application (2021-2026)
- 11.4.2 Asia Pharmaceutical Outsourcing Analytical Testing Revenue by Application (2027-2032)
- 11.5 Asia Pharmaceutical Outsourcing Analytical Testing Revenue Share by Application (2021-2032)
- 11.6 Asia Pharmaceutical Outsourcing Analytical Testing Revenue by Country
- 11.6.1 Asia Pharmaceutical Outsourcing Analytical Testing Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Pharmaceutical Outsourcing Analytical Testing Revenue by Country (2021-2026)
- 11.6.3 Asia Pharmaceutical Outsourcing Analytical Testing Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Pharmaceutical Outsourcing Analytical Testing Revenue (2021-2032)
- 12.2 SAMEA Pharmaceutical Outsourcing Analytical Testing Revenue by Type (2021-2032)
- 12.2.1 SAMEA Pharmaceutical Outsourcing Analytical Testing Revenue by Type (2021-2026)
- 12.2.2 SAMEA Pharmaceutical Outsourcing Analytical Testing Revenue by Type (2027-2032)
- 12.3 SAMEA Pharmaceutical Outsourcing Analytical Testing Revenue Share by Type (2021-2032)
- 12.4 SAMEA Pharmaceutical Outsourcing Analytical Testing Revenue by Application (2021-2032)
- 12.4.1 SAMEA Pharmaceutical Outsourcing Analytical Testing Revenue by Application (2021-2026)
- 12.4.2 SAMEA Pharmaceutical Outsourcing Analytical Testing Revenue by Application (2027-2032)
- 12.5 SAMEA Pharmaceutical Outsourcing Analytical Testing Revenue Share by Application (2021-2032)
- 12.6 SAMEA Pharmaceutical Outsourcing Analytical Testing Revenue by Country
- 12.6.1 SAMEA Pharmaceutical Outsourcing Analytical Testing Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Pharmaceutical Outsourcing Analytical Testing Revenue by Country (2021-2026)
- 12.6.3 SAMEA Pharmaceutical Outsourcing Analytical Testing Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst